Savara Inc. Logo

Savara Inc.

SVRA

(0.5)
Stock Price

3,65 USD

-58.35% ROA

-58.99% ROE

-9.17x PER

Market Cap.

622.191.780,00 USD

26.18% DER

0% Yield

0% NPM

Savara Inc. Stock Analysis

Savara Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Savara Inc. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (30%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 ROE

Negative ROE (-39.99%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

3 ROA

The stock's ROA (-37.61%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

4 PBV

The stock's high Price-to-Book Value (P/BV) ratio (6.5x) suggests it's overvalued, potentially making it an expensive investment.

5 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

6 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

7 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

8 Graham Number

The company's Graham number indicates that it is overvalued compared to its stock price, suggesting a potentially unfavorable investment opportunity.

9 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

10 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (0) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

Savara Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Savara Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Savara Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Savara Inc. Revenue
Year Revenue Growth
2000 0
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 496.059 100%
2006 0 0%
2007 500.000 100%
2008 500.000 0%
2009 300.000 -66.67%
2010 488.959 38.65%
2011 0 0%
2012 0 0%
2013 0 0%
2014 1.548 100%
2015 54 -2766.67%
2016 400.000 99.99%
2017 0 0%
2018 0 0%
2019 0 0%
2020 257.000 100%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Savara Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2000 1.017.198
2001 946.419 -7.48%
2002 282.966 -234.46%
2003 748.997 62.22%
2004 2.744.328 72.71%
2005 8.682.498 68.39%
2006 12.001.212 27.65%
2007 15.934.409 24.68%
2008 17.922.183 11.09%
2009 6.507.650 -175.4%
2010 3.688.762 -76.42%
2011 5.758.000 35.94%
2012 8.088.152 28.81%
2013 12.902.263 37.31%
2014 19.435.000 33.61%
2015 28.264.000 31.24%
2016 8.182.000 -245.44%
2017 18.512.000 55.8%
2018 37.173.000 50.2%
2019 38.781.000 4.15%
2020 35.038.000 -10.68%
2021 28.991.000 -20.86%
2022 27.879.000 -3.99%
2023 55.468.000 49.74%
2023 44.262.000 -25.32%
2024 70.468.000 37.19%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Savara Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2000 0
2001 2.038.130 100%
2002 1.388.020 -46.84%
2003 1.585.596 12.46%
2004 4.018.453 60.54%
2005 4.901.002 18.01%
2006 7.236.437 32.27%
2007 8.678.853 16.62%
2008 9.719.613 10.71%
2009 4.998.307 -94.46%
2010 5.320.073 6.05%
2011 7.600.978 30.01%
2012 7.519.405 -1.08%
2013 8.517.781 11.72%
2014 9.488.000 10.23%
2015 10.963.000 13.45%
2016 2.820.000 -288.76%
2017 11.081.000 74.55%
2018 10.654.000 -4.01%
2019 13.081.000 18.55%
2020 14.264.000 8.29%
2021 12.350.000 -15.5%
2022 10.929.000 -13%
2023 16.588.000 34.12%
2023 15.668.000 -5.87%
2024 22.160.000 29.3%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Savara Inc. EBITDA
Year EBITDA Growth
2000 -1.811.168
2001 2.717.581 166.65%
2002 -1.716.778 258.3%
2003 -2.338.196 26.58%
2004 -6.762.781 65.43%
2005 -1.507.781 -348.53%
2006 -8.155.491 81.51%
2007 -24.113.262 66.18%
2008 -26.591.832 9.32%
2009 -11.159.422 -138.29%
2010 -8.517.407 -31.02%
2011 -13.359.000 36.24%
2012 -15.539.044 14.03%
2013 -21.361.128 27.26%
2014 -28.652.000 25.45%
2015 -39.227.000 26.96%
2016 -10.602.000 -270%
2017 -29.593.000 64.17%
2018 -26.135.000 -13.23%
2019 -25.010.000 -4.5%
2020 -47.714.000 47.58%
2021 -40.266.000 -18.5%
2022 -37.876.000 -6.31%
2023 -72.056.000 47.44%
2023 -59.133.000 -21.85%
2024 -92.484.000 36.06%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Savara Inc. Gross Profit
Year Gross Profit Growth
2000 0
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 496.059 100%
2006 0 0%
2007 500.000 100%
2008 500.000 0%
2009 300.000 -66.67%
2010 488.959 38.65%
2011 0 0%
2012 0 0%
2013 0 0%
2014 1.548 100%
2015 -145.946 101.06%
2016 400.000 136.49%
2017 -363.000 210.19%
2018 -526.000 30.99%
2019 -1.010.000 47.92%
2020 221.962 555.03%
2021 -367.000 160.48%
2022 -167.000 -119.76%
2023 0 0%
2023 -44.262.000 100%
2024 -276.000 -15936.96%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Savara Inc. Net Profit
Year Net Profit Growth
2000 -3.701.084
2001 -16.339.120 77.35%
2002 -2.105.727 -675.94%
2003 -2.332.077 9.71%
2004 -6.701.048 65.2%
2005 -24.782.646 72.96%
2006 -29.331.773 15.51%
2007 -22.142.040 -32.47%
2008 -26.647.493 16.91%
2009 -11.325.058 -135.3%
2010 -8.450.922 -34.01%
2011 -13.260.000 36.27%
2012 -15.559.489 14.78%
2013 -21.480.285 27.56%
2014 -28.702.000 25.16%
2015 -39.842.000 27.96%
2016 -10.923.000 -264.75%
2017 -29.797.000 63.34%
2018 -61.516.000 51.56%
2019 -105.025.000 41.43%
2020 -51.097.000 -105.54%
2021 -45.296.000 -12.81%
2022 -38.946.000 -16.3%
2023 -66.396.000 41.34%
2023 -54.698.000 -21.39%
2024 -88.972.000 38.52%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Savara Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2000 -770
2001 -1.960 60.77%
2002 -235 -734.04%
2003 -121 -95.83%
2004 -231 48.05%
2005 -725 68.09%
2006 -694 -4.47%
2007 -431 -61.16%
2008 -517 16.67%
2009 -170 -205.33%
2010 -45 -284.09%
2011 -33 -37.5%
2012 -23 -45.45%
2013 -20 -15.79%
2014 -16 -18.75%
2015 -17 5.88%
2016 -3 -466.67%
2017 -2 -200%
2018 -2 0%
2019 -3 50%
2020 -1 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Savara Inc. Free Cashflow
Year Free Cashflow Growth
2000 -2.152.037
2001 -1.727.194 -24.6%
2002 -1.104.309 -56.4%
2003 -2.263.485 51.21%
2004 -5.481.163 58.7%
2005 -11.884.614 53.88%
2006 -15.945.656 25.47%
2007 -19.770.449 19.35%
2008 -23.852.559 17.11%
2009 -12.616.416 -89.06%
2010 -8.369.750 -50.74%
2011 -13.878.716 39.69%
2012 -14.185.043 2.16%
2013 -17.835.743 20.47%
2014 -24.792.000 28.06%
2015 -33.114.000 25.13%
2016 -8.378.000 -295.25%
2017 -28.729.000 70.84%
2018 -39.416.000 27.11%
2019 -45.271.000 12.93%
2020 -43.130.000 -4.96%
2021 -40.138.000 -7.45%
2022 -34.563.000 -16.13%
2023 -51.357.000 32.7%
2023 -13.203.000 -288.98%
2024 -22.516.000 41.36%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Savara Inc. Operating Cashflow
Year Operating Cashflow Growth
2000 -2.148.292
2001 -1.711.101 -25.55%
2002 -1.101.939 -55.28%
2003 -2.247.109 50.96%
2004 -5.175.390 56.58%
2005 -11.646.829 55.56%
2006 -15.773.544 26.16%
2007 -19.643.190 19.7%
2008 -23.787.604 17.42%
2009 -12.616.416 -88.54%
2010 -8.341.237 -51.25%
2011 -13.466.954 38.06%
2012 -13.918.868 3.25%
2013 -17.788.962 21.76%
2014 -24.645.000 27.82%
2015 -32.949.000 25.2%
2016 -8.370.000 -293.66%
2017 -28.234.000 70.35%
2018 -39.275.000 28.11%
2019 -45.123.000 12.96%
2020 -39.836.000 -13.27%
2021 -40.081.000 0.61%
2022 -34.554.000 -16%
2023 -51.061.000 32.33%
2023 -13.160.000 -288%
2024 -22.495.000 41.5%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Savara Inc. Capital Expenditure
Year Capital Expenditure Growth
2000 3.745
2001 16.093 76.73%
2002 2.370 -579.03%
2003 16.376 85.53%
2004 305.773 94.64%
2005 237.785 -28.59%
2006 172.112 -38.16%
2007 127.259 -35.25%
2008 64.955 -95.92%
2009 0 0%
2010 28.513 100%
2011 411.762 93.08%
2012 266.175 -54.7%
2013 46.781 -468.98%
2014 147.000 68.18%
2015 165.000 10.91%
2016 8.000 -1962.5%
2017 495.000 98.38%
2018 141.000 -251.06%
2019 148.000 4.73%
2020 3.294.000 95.51%
2021 57.000 -5678.95%
2022 9.000 -533.33%
2023 296.000 96.96%
2023 43.000 -588.37%
2024 21.000 -104.76%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Savara Inc. Equity
Year Equity Growth
2000 14.610.263
2001 -638.486 2388.27%
2002 -852.730 25.12%
2003 4.120.313 120.7%
2004 12.390.391 66.75%
2005 -7.828.616 258.27%
2006 19.957.748 139.23%
2007 31.034.540 35.69%
2008 5.995.235 -417.65%
2009 6.673.530 10.16%
2010 26.685.341 74.99%
2011 56.779.000 53%
2012 41.792.394 -35.86%
2013 47.807.839 12.58%
2014 58.658.000 18.5%
2015 23.889.000 -145.54%
2016 -35.875.000 166.59%
2017 119.309.000 130.07%
2018 108.219.000 -10.25%
2019 101.698.000 -6.41%
2020 64.383.000 -57.96%
2021 144.498.000 55.44%
2022 107.778.000 -34.07%
2023 146.544.000 26.45%
2023 140.372.000 -4.4%
2024 101.731.000 -37.98%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Savara Inc. Assets
Year Assets Growth
2000 14.878.834
2001 278.006 -5251.98%
2002 130.345 -113.28%
2003 4.283.356 96.96%
2004 13.608.787 68.53%
2005 23.621.773 42.39%
2006 52.798.385 55.26%
2007 34.541.625 -52.85%
2008 10.709.258 -222.54%
2009 9.027.217 -18.63%
2010 28.486.817 68.31%
2011 61.856.000 53.95%
2012 46.971.815 -31.69%
2013 55.249.972 14.98%
2014 70.500.000 21.63%
2015 54.217.000 -30.03%
2016 28.934.000 -87.38%
2017 159.628.000 81.87%
2018 152.287.000 -4.82%
2019 136.203.000 -11.81%
2020 97.745.000 -39.35%
2021 176.598.000 44.65%
2022 139.777.000 -26.34%
2023 182.072.000 23.23%
2023 177.564.000 -2.54%
2024 139.670.000 -27.13%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Savara Inc. Liabilities
Year Liabilities Growth
2000 268.571
2001 916.492 70.7%
2002 983.075 6.77%
2003 163.043 -502.95%
2004 1.218.396 86.62%
2005 31.450.389 96.13%
2006 32.840.637 4.23%
2007 3.507.085 -836.41%
2008 4.714.023 25.6%
2009 2.353.687 -100.28%
2010 1.801.476 -30.65%
2011 5.077.000 64.52%
2012 5.179.421 1.98%
2013 7.442.133 30.4%
2014 11.842.000 37.15%
2015 30.328.000 60.95%
2016 64.809.000 53.2%
2017 40.319.000 -60.74%
2018 152.287.000 73.52%
2019 34.505.000 -341.35%
2020 33.362.000 -3.43%
2021 32.100.000 -3.93%
2022 31.999.000 -0.32%
2023 35.528.000 9.93%
2023 37.192.000 4.47%
2024 37.939.000 1.97%

Savara Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0.41
Price to Earning Ratio
-9.17x
Price To Sales Ratio
0x
POCF Ratio
-9.6
PFCF Ratio
-8.64
Price to Book Ratio
6.78
EV to Sales
0
EV Over EBITDA
-7.78
EV to Operating CashFlow
-8.69
EV to FreeCashFlow
-8.68
Earnings Yield
-0.11
FreeCashFlow Yield
-0.12
Market Cap
0,62 Bil.
Enterprise Value
0,62 Bil.
Graham Number
2.27
Graham NetNet
0.46

Income Statement Metrics

Net Income per Share
-0.41
Income Quality
0.96
ROE
-0.59
Return On Assets
-0.54
Return On Capital Employed
-0.63
Net Income per EBT
1
EBT Per Ebit
0.93
Ebit per Revenue
0
Effective Tax Rate
0.02

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0
Operating Profit Margin
0
Pretax Profit Margin
0
Net Profit Margin
0

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.39
Free CashFlow per Share
-0.39
Capex to Operating CashFlow
-0
Capex to Revenue
0
Capex to Depreciation
0.37
Return on Invested Capital
-0.62
Return on Tangible Assets
-0.58
Days Sales Outstanding
0
Days Payables Outstanding
4663.74
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0.08
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,67
Book Value per Share
0,56
Tangible Book Value per Share
0.5
Shareholders Equity per Share
0.56
Interest Debt per Share
0.15
Debt to Equity
0.26
Debt to Assets
0.19
Net Debt to EBITDA
-0.03
Current Ratio
11.29
Tangible Asset Value
0,09 Bil.
Net Current Asset Value
0,09 Bil.
Invested Capital
126953000
Working Capital
0,12 Bil.
Intangibles to Total Assets
0.08
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
849500
Debt to Market Cap
0.04

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Savara Inc. Dividends
Year Dividends Growth

Savara Inc. Profile

About Savara Inc.

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

CEO
Mr. Matthew Pauls J.D., M.B.A
Employee
37
Address
Building III
Austin, 78746

Savara Inc. Executives & BODs

Savara Inc. Executives & BODs
# Name Age
1 Ms. Anne Erickson
Chief Business Officer
70
2 Ms. Kate McCabe J.D.
Senior Vice President & General Counsel
70
3 Mr. Matthew Pauls J.D., M.B.A.
Chairman & Chief Executive Officer
70
4 Mr. David L. Lowrance CPA
Chief Financial Officer, Chief Administrative Officer & Secretary
70
5 Mr. Robert Lutz M.B.A.
Chief Operating Officer
70
6 Brian Maurer
Head of Clinical Operations
70
7 Mr. Charles LaPree
Senior Vice President of Global Regulatory Affairs & Quality Assurance
70
8 Dr. Peter Clarke Ph.D.
Executive Vice President of Global Technical Operations
70
9 Dr. Raymond Dennis Pratt FACP, M.D.
Chief Medical Officer
70
10 Mr. Scott L. Wilhoit
Executive Vice President of Global Commercial
70

Savara Inc. Competitors